Asthma drug staves off food allergies in up to 68% of patients
Omalizumab, currently used to treat asthma, has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, including peanuts, following accidental exposure. While not a cure, the now FDA-approved drug could improve the quality of life for food allergy sufferers.The incidence of food allergies has risen globally over the last decade, affecting approximately one in 10 adults and one in 12 children. The cause of the rise is unknown,…